Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer

Specific Pomegranate Juice Components as Potential Inhibitors of Prostate Cancer Metastasis

(2014) Lei Wang et al.   Translational Oncology

Luteolin Inhibits Proliferation Induced by IGF-1 Pathway Dependent ERα in Human Breast Cancer MCF-7 Cells

(2012) Li-Meng Wang et al.   Asian Pacific Journal of Cancer Prevention

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Breast Cancer Chemoprevention: Old and New Approaches

(2012) Massimiliano Cazzaniga et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Strategies for the discovery and development of therapies for metastatic breast cancer

(2012) Bedrich L. Eckhardt et al.   NATURE REVIEWS DRUG DISCOVERY

Chemokines and Cancer: A Fatal Attraction

(2011) Raffaella Bonecchi et al.   CANCER CELL

Luteolin induces apoptotic cell death through AIF nuclear translocation mediated by activation of ERK and p38 in human breast cancer cell lines

(2011) Moon Jung Kim et al.   CELL BIOLOGY INTERNATIONAL

CXCL12 (SDF1 )-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?

(2011) D. G. Duda et al.   CLINICAL CANCER RESEARCH

Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells

(2011) Lei Wang et al.   Integrative Biology

Pomegranate (Punica granatum) Juices: Chemical Composition, Micronutrient Cations, and Antioxidant Capacity

(2011) Chiraz El Kar et al.   JOURNAL OF FOOD SCIENCE

The Antioxidant Potency of Punica granatum L. Fruit Peel Reduces Cell Proliferation and Induces Apoptosis on Breast Cancer

(2011) Miris Dikmen et al.   JOURNAL OF MEDICINAL FOOD

Pomegranate Ellagitannin-Derived Compounds Exhibit Antiproliferative and Antiaromatase Activity in Breast Cancer Cells In vitro

(2010) L. S. Adams et al.   Cancer Prevention Research

RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53

(2010) Sindy Sohr et al.   CELL CYCLE

CXCL12 (SDF-1)/CXCR4 Pathway in Cancer

(2010) B. A. Teicher et al.   CLINICAL CANCER RESEARCH

RHAMM Promotes Interphase Microtubule Instability and Mitotic Spindle Integrity through MEK1/ERK1/2 Activity

(2010) Cornelia Tolg et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer

(2010) Federica Marchesi et al.   JOURNAL OF NEUROIMMUNOLOGY

RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44–EGFR

(2010) Hiroko Hatano et al.   LABORATORY INVESTIGATION

Mechanisms of Motility in Metastasizing Cells

(2010) Mahmut Yilmaz et al.   MOLECULAR CANCER RESEARCH

Regulated Degradation of Spindle Assembly Factors by the Anaphase-Promoting Complex

(2010) Ling Song et al.   MOLECULAR CELL

Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer

(2010) C Caldon et al.   Cell Division

Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content via Stromal-Derived Factor-1 /CXCR4 Axis

(2009) N. Song et al.   CANCER RESEARCH

Protein kinase Cε: an oncogene and emerging tumor biomarker

(2009) Michael A Gorin et al.   Molecular Cancer

The inflammatory chemokines CCL2 and CCL5 in breast cancer

(2008) Gali Soria et al.   CANCER LETTERS

Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response

(2008) J. Helleman et al.   CLINICAL CANCER RESEARCH